PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 213 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $12,020,000 | +9.0% | 276,378 | -4.6% | 1.18% | +11.1% |
Q1 2019 | $11,030,000 | -10.4% | 289,812 | +29.0% | 1.07% | -12.5% |
Q4 2018 | $12,308,000 | -25.0% | 224,739 | -15.3% | 1.22% | -2.2% |
Q3 2018 | $16,416,000 | +48.7% | 265,255 | -22.3% | 1.25% | +51.5% |
Q2 2018 | $11,041,000 | -10.4% | 341,580 | -13.0% | 0.82% | -15.1% |
Q1 2018 | $12,328,000 | -19.9% | 392,515 | +17.4% | 0.97% | -9.8% |
Q4 2017 | $15,385,000 | +48.0% | 334,297 | +21.6% | 1.07% | +41.3% |
Q3 2017 | $10,398,000 | -10.2% | 274,842 | +13.4% | 0.76% | -11.7% |
Q2 2017 | $11,575,000 | +3461.5% | 242,293 | +3528.2% | 0.86% | +3813.6% |
Q1 2017 | $325,000 | – | 6,678 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 1,210,377 | $37,134,366 | 11.77% |
Gagnon Advisors, LLC | 180,331 | $5,532,555 | 4.63% |
GAGNON SECURITIES LLC | 565,429 | $17,347,361 | 4.35% |
ARDSLEY ADVISORY PARTNERS LP | 310,000 | $9,510,800 | 2.12% |
RICE HALL JAMES & ASSOCIATES, LLC | 968,485 | $29,713,120 | 1.89% |
AlphaCentric Advisors LLC | 103,000 | $3,160,040 | 1.79% |
1492 Capital Management LLC | 79,687 | $2,444,797 | 1.58% |
ARDSLEY ADVISORY PARTNERS LP | 149,000 | $4,571,320 | 1.02% |
OUTFITTER FINANCIAL LLC | 32,305 | $991,117 | 0.93% |
Rock Springs Capital Management LP | 1,055,500 | $32,382,740 | 0.87% |